The cell cryopreservation market is used for preservation of cells and tissue by cooling them to very low sub-zero temperatures.At such low temperatures, any biological activity, including cell division and metabolism, gets stopped, thereby enabling the long-term preservation of tissues and cells. Some of the key advantages of cell cryopreservation include preservation of cell function after thawing, maintaining viable cell populations for long durations, and avoiding cell morphology changes. The growing prevalence of chronic diseases and genetic disorders has fueled the demand for regenerative medicine which involves transplantation of preserved cells and tissues. This has propelled the need for reliable cell cryopreservation techniques.
The Global Cell Cryopreservation Market is estimated to be valued at US$ 263.58 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries.
The growing demand for preservation of blood, cord blood, sperm, embryo cells and tissue samples is a major factor boosting the cell cryopreservation market growth. Increasing incidences of chronic diseases like cancer requiringStem cell therapies and organ transplantation. Technological advancements such as introduction of robotic cryopreservation systems to improve sample temperature maintenance and reduce manual errors have aided market growth.
Market Trends
1) Increased funding for regenerative medicine research: Rising funding from government agencies and private firms for stem cell research driven by potential clinical applications is fueling the adoption of cell cryopreservation techniques.
2) Development of integrated cryopreservation platforms: Manufacturers are focusing on developing end-to-end integrated cell processing and cryopreservation platforms equipped with robotic capabilities for improved process control, automation, and storage capabilities.
Market Opportunities
1) Potential in cord blood banking: Umbilical cord blood contains stem cells that can be preserved and later used in cell therapies and regenerative medicine, driving opportunities in commercial cord blood banking.
2) Growth in emerging economies: Improving healthcare infrastructure and increasing healthcare spending in developing nations of Asia Pacific and Latin America provides significant growth potential for cell cryopreservation market players targeting these regions.
Impact of COVID-19 on Cell Cryopreservation Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global cell cryopreservation market. Various restrictions imposed by governments worldwide to contain the spread of the virus led to disrupted supply chains, delayed research projects and elective medical procedures. This adversely affected the demand for cell cryopreservation products and services in 2020. However, with the development and approval of multiple vaccines, lockdown restrictions are gradually lifting across regions. This is enabling a revival in research activities and healthcare services.
The pre-COVID situation saw steady growth in the market driven by rising investments in stem cell research, growing prevalence of cancer and increasing adoption of regenerative medicine. several biotech and pharmaceutical companies were focusing on developing novel therapeutics using cryopreserved cells. However, during the peak of the pandemic in 2020, the market witnessed a decline as research projects faced delays and hospitals prioritized COVID-19 treatment over elective procedures like cryopreservation of umbilical cord blood and tissue.
As the pandemic situation improves with increasing vaccination rates globally, the cell cryopreservation market is anticipated to get back on the growth trajectory from 2022 onwards. Research funding is being restored and healthcare systems are catching up with the backlog created during the outbreak. Market players are also implementing new safety protocols and strategies to minimize future disruptions. The long-term outlook remains positive due to ongoing advances in regenerative medicine and stem cell therapeutics.
North American Region Dominates Global Cell Cryopreservation Market
The Cell Cryopreservation Market Growth continues to be dominated by North America, holding the largest share in terms of value. The presence of advanced research infrastructure, large biopharma industry and favorable government funding for stem cell research have been major attractions for market players in the region. Countries like the US and Canada house numerous global leaders and have introduced innovative therapies using cryopreserved cells. Additionally, North America also has a growing umbilical cord blood banking industry to support the increasing demand.
Asia Pacific Emerging as the Fastest Growing Regional Market
Asia Pacific is poised to register the fastest growth during the forecast period owing to increasing healthcare expenditures, rising medical tourism and growing focus of global market players. Rapid economic development, large patient pools and improving research ecosystem make China, India and other Southeast Asian countries highly lucrative. Initiatives like Make in India and favorable regulations are encouraging domestic innovation as well as attracting Foreign Direct Investments in the cell cryopreservation domain. With healthcare modernization projects in many APAC nations, the Asia Pacific market for cell cryopreservation is expected to exhibit strong gains through 2030
Explore more information on this topic, Please visit-
Explore more trending article-
https://coolbio.org/virtual-reality-is-changing-the-face-of-gaming-industry/
The Cryopreservation Cell Lines Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cryopreservation cell lines market include Thermo Fisher Scientific, Inc., ATCC, Corning Incorporated, ABM Inc, Zenbio, REPROCELL USA Inc. and many more.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cryopreservation Cell Lines Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cryopreservation-cell-lines-market/download-sampleMarket DynamicsThey prevent vascular damage affected during the expansion of blood vessels and find applications in reparative and regenerative medicine and cell-based therapy.
